Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral pulse versus daily calcitriol in hemodialysis patients with secondary hyperparathyroidism
IRCT20111024007892N10Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of calcitriol in secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Serum calcium level, Serum phosphorus level and 3 more. Started Jan 2021; status: completed.
02
Drugs
calcitriol
03
Conditions
secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20111024007892N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111024007892N10.